Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

BACKGROUND: Preliminary data suggest that psilocybin-assisted treatment produces substantial and rapid antidepressant effects in patients with major depressive disorder (MDD), but little is known about long-term outcomes. AIMS: This study sought to examine the efficacy and safety of psilocybin throu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gukasyan, Natalie, Davis, Alan K, Barrett, Frederick S, Cosimano, Mary P, Sepeda, Nathan D, Johnson, Matthew W, Griffiths, Roland R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864328/
https://www.ncbi.nlm.nih.gov/pubmed/35166158
http://dx.doi.org/10.1177/02698811211073759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864328/
https://www.ncbi.nlm.nih.gov/pubmed/35166158
http://dx.doi.org/10.1177/02698811211073759

Ejemplares similares